[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]LI D,SHI J,DONG X,et al.Epidemiological characteristics and risk factors of lung adenocarcinoma:A retrospective observational study from North China[J].Frontiers in Oncology,2022,12:892571.
[3]PENG J,LIU J,LIU H,et al.Prognostic value of microRNAs in patients with small cell lung cancer:A Meta-analysis[J].World Journal of Surgical Oncology,2022,20(1):381.
[4]XU S,WANG Q,KANG Y,et al.Long noncoding RNAs control the modulation of immune checkpoint molecules in cancer[J].Cancer Immunol Res,2020,8(7):937-951.
[5]刘剑锋,何攀,潘德锋.miR-218靶向Bmi-1抑制急性早幼粒细胞白血病细胞增殖的研究[J].中国实验血液学杂志,2020,28(3):815-820.
LIU JF,HE P,PAN DF.MiR-218 targeting Bmi-1 inhibits proliferation of acute promyelocyticleukemia cells[J].Chin J Exp Hematol,2020,28(3):815-820.
[6]WU Y,TIAN S,CHEN Y,et al.miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway[J].Pathology-Research and Practice,2018,215(2):243-250.
[7]WU J,JIANG Z,XIE Y,et al.miR-218 suppresses the growth of hepatocellular carcinoma by inhibiting the expression of proto-oncogene Bmi-1[J].Journal of BUON,2018,23(3):604-610.
[8]XIONG D,YE Y,KUANG B,et al.Prognostic value of Bmi-1 oncoprotein expression in non-small cell lung cancer[J].Frontiers in Laboratory Medicine,2018,2(3):109-115.
[9]张苑,韩鹏凯,王静,等.miR-28靶向LASP调控TGF-β/Smad信号通路调节肺癌细胞的侵袭和转移[J].中国免疫学杂志,2021,37(19):2338-2344.
ZHANG Y,HAN PK,WANG J,et al.miR-218 targets LASP1 in regulation of TGF-β/Smad signaling pathway regulating invasion and metastasis of lung cancer cells[J].Chin J Immun,2021,37(19):2338-2344.
[10]CHAKRABORTY S,NATH D.A study on microRNAs targeting the genes overexpressed in lung cancer and their codon usage patterns[J].Molecular Biotechnology,2022,64(10):1095-1119.
[11]LAI X,SCHMITZ U,VERA J,et al.The role of microRNAs in cancer biology and therapy from a systems biology perspective[J].Advances in Experimental Medicine and Biology,2022,1385:21-22.
[12]吴哲,魏志鸿,陈少华.结直肠癌组织中长链非编码RNA NEAT1和miR-218-5p的表达及其与患者预后的关系[J].国际消化病杂志,2022,42(1):33-37,49.
WU Z,WEI ZH,CHEN SH.Relationship between expression of lncRNA NEAT1 and miR-218-5p in colorectal cancer and prognosis of patients[J].Int J Digest Dis,2022,42(1):33-37,49.
[13]ZARE A,AHADI A,LARKI P,et al.The clinical significance of miR-335,miR-124,miR-218 and miR-484 downregulation in gastric cancer[J].Molecular Biology Reports,2018,4(6):1587-1595.
[14]ELFIKY A,MOHAMED R,ABD E,et al.Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression[J].International Journal of Pharmaceutics,2021,610:121256.
[15]赵一宁,盖俊达,李庆昌.MicroRNA-218通过EMT抑制肿瘤侵袭转移的研究进展[J].现代肿瘤医学,2019,27(17):3134-3137.
ZHAO YN,GAI JD,LI QC.Advances in microRNA-218 inhibiting tumor invasion and metastasis through EMT[J].Modern Oncology,2019,27(17):3134-3137.
[16]WANG R,XUE X,WANG Y,et al.BMI1 deficiency results in female infertility by activating p16/p19 signaling and increasing oxidative stress[J].International Journal of Biological Sciences,2019,15(4):870-881.
[17]CHEN S,LI H,CHEN S,et al.BMI1 promotes the proliferation and inhibits autophagy of breast cancer cells by activating COPZ1[J].Clinical and Translational Oncology,2022,24(1):2166-2174.
[18]GUO Y,ZHOU G,MA Q,et al.Bmi-1 directly upregulates glucose transporter 1 in human gastric adenocarcinoma[J].Open Life Sciences,2022,17(1):261-271.
[19]HU C,ZHANG Q,TANG Q,et al.CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer[J].Journal of Cellular and Molecular Medicine,2020,24(1):618-631.